Skip to main content
Fanli Digital Technology Co., Ltd logo

Fanli Digital Technology Co., Ltd — Investor Relations & Filings

Ticker · 600228 ISIN · CNE000000Y78 Shanghai Stock Exchange Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Filings indexed 2,248 across all filing types
Latest filing 2020-12-23 Capital/Financing Update
Country CN China
Listing Shanghai Stock Exchange 600228

About Fanli Digital Technology Co., Ltd

https://corp.fanli.com/

Fanli Digital Technology Co., Ltd. provides e-commerce integration and digital marketing services. The company operates a comprehensive platform that connects consumers with various online retail ecosystems through value-added services such as cash-back rewards, discount coupons, and promotional insights. Its core business model focuses on performance-based marketing, utilizing data-driven strategies to facilitate sales conversions for brand partners. Key offerings include brand promotion, user loyalty management, and targeted advertising solutions. By integrating diverse shopping channels into a single interface, the company optimizes the consumer purchasing journey and provides brands with scalable traffic acquisition tools. The platform serves as a strategic intermediary, leveraging user behavioral data to enhance marketing efficiency and provide measurable returns for merchants while delivering cost savings to a broad user base.

Recent filings

Filing Released Lang Actions
江西昌九生物化工股份有限公司重大资产置换、发行股份及支付现金购买资产并募集配套资金暨关联交易报告书(草案)(修订稿)摘要
Capital/Financing Update Classification · 95% confidence The document is titled as a "重大资产置换、发行股份及支付现金购买资产并募集配套资金暨关联交易报告书(草案)摘要" which translates to "Summary of the Report on Major Asset Swap, Issuance of Shares and Payment of Cash to Purchase Assets and Raising Supporting Funds and Related Party Transactions (Draft)". It details a major asset restructuring transaction involving asset swaps, issuance of shares, cash payments for asset purchases, and fundraising. The document includes detailed descriptions of the transaction parties, asset valuations, share issuance pricing, and compliance with regulatory requirements such as approval by the China Securities Regulatory Commission (CSRC) and Shanghai Stock Exchange. It also discusses the transaction's classification as a major asset restructuring and related party transaction, with references to relevant laws and regulations. The document is substantive, lengthy (15,000 characters), and contains detailed financial and transaction data. This matches the definition of a Capital/Financing Update (CAP) filing, which covers updates on company fundraising, financing activities, or capital structure changes. It is not an announcement of a report publication, nor a full annual or interim report, nor a proxy or voting announcement. Therefore, the appropriate classification is CAP.
2020-12-23 Chinese
江西昌九生物化工股份有限公司重大资产置换、发行股份及支付现金购买资产并募集配套资金暨关联交易报告书(草案)(修订稿)
Regulatory Filings
2020-12-23 Chinese
华泰联合证券有限责任公司关于昌九生化重大资产置换、发行股份及支付现金购买资产并募集配套资金暨关联交易之独立财务顾问报告(修订稿)
Capital/Financing Update Classification · 95% confidence The document is a detailed independent financial advisor report related to a major asset swap, issuance of shares, cash payment for asset purchase, and fundraising related to a significant transaction involving Jiangxi Changjiu Biochemical Co., Ltd. It includes extensive financial data, transaction details, asset valuations, share issuance pricing, and compliance with regulatory requirements. The document references the China Securities Regulatory Commission (CSRC) and Shanghai Stock Exchange rules, indicating it is a formal report supporting a major corporate restructuring and related financing activities. The content is comprehensive and substantive, not merely an announcement or summary. It is not a general annual report, earnings release, or management discussion but a specialized financial advisory report for a major asset restructuring and capital raising transaction. This fits the category of Capital/Financing Update (CAP) as it covers issuance of shares, cash payments, and fundraising details in a major transaction context.
2020-12-23 Chinese
关于重大资产重组方案调整的公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement regarding adjustments to a major asset restructuring plan by Jiangxi Changjiu Biochemical Co., Ltd. It discusses changes in the fundraising targets, issuance of shares, asset swaps, and related agreements. The content includes detailed financial figures, transaction parties, share issuance prices, and legal compliance references. The document is not a full annual or interim report but a specific announcement about a major asset restructuring and related capital raising activities. It is not a simple announcement of a report publication but a substantive disclosure of a transaction. The document fits the category of Capital/Financing Update (CAP) because it details changes in fundraising, issuance of shares, and capital structure related to a major asset restructuring. Therefore, the appropriate classification is CAP with high confidence.
2020-12-23 Chinese
关于中国证监会并购重组委审核公司重大资产置换、发行股份及支付现金购买资产并募集配套资金暨关联交易事项会议安排的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the scheduling of a review meeting by the China Securities Regulatory Commission's M&A Review Committee for a major asset swap, share issuance, cash purchase of assets, and related party transactions by the company. It mentions the company's commitment letter and the planned stock suspension and resumption related to the M&A process. The document does not contain financial statements or detailed financial data but is an update on the company's capital restructuring and financing activities. Therefore, it fits best under Capital/Financing Update (CAP). The document length is short and it is not a report publication announcement or regulatory filing. Confidence is high due to clear references to asset purchase, share issuance, and fundraising activities.
2020-12-18 Chinese
关于收到中国证监会并购重组委会审核公司重大资产置换、发行股份及支付现金购买资产并募集配套资金暨关联交易事项的提示性公告
M&A Activity Classification · 95% confidence The document is a short announcement (685 characters) from a company about receiving a notice from the China Securities Regulatory Commission regarding the review of a major asset swap, share issuance, cash purchase of assets, and related party transactions. It mentions the upcoming meeting of the M&A review committee and the suspension of trading on the meeting day. The document does not contain detailed financial data or the full report itself but is an update on the status of a merger and acquisition review process. Therefore, it fits best under the category of M&A Activity (TAR) as it relates to merger proposals and takeover bids announcements.
2020-12-17 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.